glp-1 probiotic canada Probiotic+® GLP-1 Probiotic for Weight Support

Impact of pretransplant and new-onset diabetes after transplantation on the risk of major adverse cardiovascular events in kidney transplant recipients: a population-based cohort study

Conclusion An increase in CV awareness and CV risk screening is expected to lead to a greater adoption of medications with CV benefits, further reducing morbidity as well as mortality among patients with T2D

The industry is developing new treatments to counteract this

Figure 2a: From step 1 (left) to steps 2 and 3 (right)

Retatrutide, an experimental weight loss drug that hasnt been submitted for FDA-approval, is being prescribed in weight loss clinics and med spas across the country